First major arrest made under AMLA: Probe ordered into ‘Future Vision' scam: DG NAB
Victims of Future Vision scam, Bahria Cuisines scam, Omega Housing scandal, New Lahore City, Pak-Arab Housing Society, Khayaban-e-Amin Housing Society, Eden Garden, and Professional Cooperative Housing Society earnestly approached the forum to present their grievances by seeking institutional support and intervention for their redressal.
While addressing the open court, DG NAB Lahore, Ghulam Safdar Shah reaffirmed the Bureau's unwavering commitment to safeguarding public interest and upholding the principles of transparency, accountability, and justice. He stated that NAB Lahore has executed its first major arrest under the Anti-Money Laundering Act (AMLA), marking a pivotal milestone in the Bureau's pursuit against financial misappropriation.
He further disclosed that, in response to a multitude of complaints received from the general public, a direct inquiry has been formally authorised in the Future Vision Scam. However, in order to prevent further financial exploitation, categorical instructions have been issued that individuals operating fraudulent Ponzi schemes be immediately placed on the Exit Control List (ECL).
The DG underlined that all operations are being undertaken in strict compliance with the directives of the Honourable Chairman NAB, whose guidance remains instrumental in driving the institution's citizen-centric agenda. NAB's resolve remains firm to bring all culpable elements to justice and to ensure that the aggrieved parties are duly compensated, he added. He further remarked that, unlike prior practices, the current model of Khuli Katcheri encourages direct interface between victims and housing society administrations, thereby facilitating pragmatic and result-oriented dispute resolution. Weekly monitoring of progress on individual cases is being conducted under his supervision is meant to maintain fair momentum and institutional vigilance. Owing to the relentless efforts and dedicated interventions of NAB Lahore, billions of rupees have been recovered, benefitting thousands of citizens who had fallen prey to fraudulent schemes.
The victims present on the occasion expressed profound appreciation for the dynamic leadership and proactive measures taken by DG NAB Lahore, and acknowledged that the regular convening of open courts, is a reflection of Chairman NAB's unwavering commitment to public facilitation and institutional transparency.
Copyright Business Recorder, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
2 hours ago
- Business Recorder
Zimbabwe recall Brendan Taylor after completion of ICC ban
Zimbabwe have added batter Brendan Taylor to their squad for the second Test against New Zealand in Bulawayo from August 7-11 after he completed a three-and-a-half-year suspension imposed for breaching the ICC's Anti-Corruption and Anti-Doping codes. Taylor, 39, was banned in 2022 after admitting receiving $15,000 from an Indian businessman in 2019. He had retired from international cricket in September 2021. He admitted taking cocaine while in India and claimed this was later used to blackmail him into spot-fixing, though he denied going through with any fixes. 'I certainly did think it was all done, but here I am – and it's an overwhelming feeling of gratitude,' Taylor said in a media release from Zimbabwe Cricket on Wednesday. 'I have to pinch myself a little to realise that I'm actually here. I've been soaking it all up and embracing every moment. 'The last year and a half has certainly been dedicated to my return. I've put in an immense amount of work – from fitness to the technical side to diet – and I'm feeling a lot leaner, fitter and mentally stronger. That's only been possible through sobriety. I feel in a wonderful space.' Taylor has played 34 Test matches since making his debut against Sri Lanka in 2004, scoring six centuries and 12 half-centuries. With 9 938 international runs across all formats, he is Zimbabwe's third-highest run-scorer. Zimbabwe's first Test in the two-game series against New Zealand started in Bulawayo on Wednesday.
Business Recorder
17 hours ago
- Business Recorder
Pharmaceutical exports: some prescriptions
'The global pharmaceutical market is in a state of flux due to major restructuring, both in terms of the demand and supply. This presents a unique opportunity for the sector in Pakistan to take timely action by positioning itself strategically to enter the global drugs market. Pakistan is well poised to gain from opportunities provided under these shuffling global patterns of demand and supply'. International Trade Centre study titled Pakistan Export Strategy – Pharmaceuticals 2023-2027. The Pharmaceutical market in Pakistan is estimated at over PKR 1.10 trillion, growing at a rate of over 15 percent according to analysts. There are over 700 pharmaceutical companies from Karachi to Khyber. In Pakistan, 80 percent of the domestic need for medicine is fulfilled by local manufacturing, whereas the other 20 percent is through imports. Most of the imports are essential and crucial drugs that cannot be manufactured locally, and at the present moment not licensed for manufacturing for specific reasons. Pakistan's pharmaceutical exports growth hit a two-decade high of 34 percent in the fiscal year ended June 30, 2025, hitting sales of USD 457 million, whereas in 2024 the exports were USD 341 million. Although the pharma sector is commended for its export performance, nevertheless, Pakistani companies should endeavour to seek new export markets. The pharma exports growth trajectory requires close liaison between the manufacturers and the regulator. The main destinations for Pakistan's pharmaceutical exports are Afghanistan, the Philippines, Uzbekistan, Sri Lanka, Cambodia and recently Iraq. Formidable efforts must be made to carve out a substantial share of the African, Middle East and Central Asia markets. In the same manner as other Pakistani products, the menace of illicit exports of pharma products which in many cases lack quality assurance, use substandard raw material, and are unethically counterfeit, while bringing in undocumented foreign proceeds, result in creating a negative image of the pharma sector. It is recommended that a pharma oversight Council be formed consisting of representatives from SIFC, Anti-Narcotics Force, Army Corps X1 and Corps X11 based in KPK and Balochistan, as well as from the Pakistan Pharmaceuticals Manufacturers Association that would identify those in this illicit trade, seal their premises, and prosecute the owners or perpetrators. This illicit trade is estimated to be around USD 90-100 million annually and is growing every year. It is an accepted fact that exports of pharmaceutical products require compliance with world-class quality assurance standards, maximum focus on health safety standards, and investment in modern technologies, including use of Artificial Intelligence. A solid foundation is imperative in order to claim a stake in the export regime, as this would enable the companies to enhance their competitiveness in the global market. According to Arshad Rahim Khan, an old pro in the pharma industry who has been appointed as TDAP Consultant on pharmaceuticals, 'currently, the sector is underdeveloped, non-compliant with international regulations (cGMP, PICs, ISO, WHO, EU, UK, US), low performing, and hence at a low entry valuation'. Haroon Qasim, a leading pharmaceutical company owner and advocate of instilling the concept of new technology in manufacturing, highlighted the role of digital technologies in revolutionising drug development, patient engagement, and pharmacovigilance. Enlightened entrepreneurs are adopting AI rapidly and are well aware of its importance in new drugs development, in improving safety of consumers, and making a well-intentioned paradigm shift in the healthcare landscape. The Institute of Chartered Accountants of Pakistan, in its study of the pharma sector, stated that 'over 90 percent of the raw material used in making of drug is imported.' Only 12 percent of API is produced in Pakistan. Specialized finished dosage form and biologicals such as vaccines, oncology, etc., continue to be imported. The current practice of importing 95 percent of the raw material, compounding active ingredients with excipients, coating the pills, and packaging the drugs, cannot continue to be the long-term goal of the sector. Heavy import dependency of active ingredients from China and India also poses significant concentration risk. Reliance of local pharmaceutical industry on India was estimated at 50 percent — 60 percent before the recent Indo-Pak conflict. Pakistan Business Council, in a study 'Unleashing the Potential of Pharmaceuticals in Pakistan', advised that 'Drug Regulatory Authority of Pakistan should continue its reforms for quality regulation and enforcement, for example, by achieving international standards, clearing certifications as per WHO Global Benchmarking Tool, and attaining the Pharmaceutical Inspection Corporation Scheme membership, which could allow market access to Stringent Regulatory Authority countries'. The depressing situation is that only four foreign companies have manufacturing facilities in the country. Ayesha T. Haq, Executive Director of Pharma Bureau, emphasized the issues impeding the growth of foreign pharmaceutical companies in Pakistan. 'The regulatory environment in Pakistan is a major obstacle to the growth of foreign pharmaceutical companies. The DRAP Act 2012, Drugs Act 1976, and Drug Pricing Policy 2018, contain numerous anomalies, including overlapping powers, unclear standard operating procedures, and irrational pricing of essential drugs. These issues have led to a lack of confidence among foreign investors.' In a transformative step aimed at modernizing trade and enhancing the global competitiveness of Pakistan's pharmaceutical sector, the Pakistan Single Window, in collaboration with DRAP, officially launched the Digital Certificate of Pharmaceutical Product. This Digital Certificate is designed to streamline cross-border pharmaceutical trade by meeting the documentation and regulatory requirements of importing countries. It replaces traditional paper-based systems with a secure, verifiable, and fully digital solution. The pharma industry must continue the momentum of export growth. A comprehensive and holistic approach is crucial, and this is possible when manufacturers are successful in lobbying and advocating the removal of challenges that hinder rapid growth and are determined to meet the high quality standards of international organizations. Pakistan lacks Bioequivalence Centers that are approved or partnered with major regulatory authorities. An Executive of a leading pharma company disclosed in an email that 'countries like Uzbekistan, Bangladesh, and India provide financial support to their pharmaceutical companies for conducting Bioequivalence studies from internationally accredited or approved centres, enabling faster product registration compared to Pakistani companies'. He further added that 'inconsistent supply and high cost of physical infrastructure, no incentives for companies to upgrade technology by importing the latest machines and equipment, exchange rate volatility, high financial costs, challenges in remittances, and frequent border closures with Afghanistan create significant challenges for export logistics to Afghanistan and CIS regions'. Most of the nearly 700 pharma manufacturers in Pakistan are focused on domestic sales, including to private and public hospitals. They do not have the critical mass to enter the export market. A number of these companies do toll manufacturing for large companies and also may not have any products registered in their names. It is now imperative that these smaller companies are encouraged to enter the export market. One suggestion floated by this writer is that a Collective be formed, initially consisting of around fifty manufacturers. The management of the Collective would be in the hands of technocrats who have in the past served in the pharma sector. The Collective would undertake steps to make these companies compliant with all conditionalities, help in procuring quality certificates, upskill their work force and managerial cadre, liaise with DRAP and other agencies, be the focal point for common procurement of raw material, and create a mutual pool of financial resources for any contingencies. The Collective will procure export orders and farm out these orders as per the facilities available in these enterprises. The pharmaceuticals would be exported under one brand and logo (say, Dawaa-Pak). However, the name of the unit could be mentioned in the packaging. The administrative expenses should be less than seven percent of the net profit, ten percent would be deposited in an escrow account in case of future needs, while eighty percent would be deposited in the member company accounts. If the enterprise has excess capacity to do toll manufacturing or direct selling, these should also be encouraged. The Collective can organize single country, single brand exhibitions in different countries such as Sri Lanka, in Africa, and in Central Asian States. An annual export target must be decided and TDAP should facilitate the project. If the idea of the Collective catches on, more enterprises who desire to enter exports could be inducted. It is imperative that smaller companies get on the bandwagon so that together, along with large manufacturers, they can soon achieve the target of USD 1 billion in national pharma exports. Over five centuries ago, Swiss physician and alchemist Paracelsus said, 'Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided.' (The writer is a former President, Karachi Chamber of Commerce and Industry) Copyright Business Recorder, 2025
Business Recorder
17 hours ago
- Business Recorder
Old car importers: Anti-Benami zone of FBR initiates big crackdown
KARACHI: The anti-Benami zone of Federal Board of Revenue (FBR) has kicked off massive crackdown against the billions of rupees Benami transactions carried out by old/used car importers during past seven years. According to the official document, which was exclusively available to the Daily Business Recorder, the anti-Benami zone has launched a comprehensive crackdown targeting the systematic abuse of the Vehicle Baggage and Gifts Scheme (VB&GS), which was designed for legitimate personal imports but has been extensively exploited by commercial importers through clearing agents with the alleged support of customs officials. The enforcement action is focusing on vehicle clearances conducted between February 2018 and May 2025, giving clearing agents just seven days to provide detailed explanations for thousands of vehicle imports processed under the personal baggage scheme. The notices have specifically accused clearing agents of concealing the true beneficial ownership of imported vehicles while systematically evading billions in taxes and duties during the seven-year period under investigation. The anti-Benami zone has demanded comprehensive documentation from clearing agents, including complete import records, customs declarations, detailed particulars of end users and true owners with names, national identity card numbers and addresses, information on all parties involved in transactions, copies of agreements and contracts, bank statements covering the entire seven-year period, and detailed explanations of how commercial vehicles qualified for the personal baggage and gifts scheme and warned to initiate criminal proceedings under multiple sections of the Benami Transactions (Prohibition) Act 2017 in case of non-compliance, showing the determination to hold all responsible accountable for this systematic exploitation of these schemes. Arshad Khurshid, Chairman of the All Pakistan Customs Clearing Agents Association, confirmed that the anti-Benami zone has issued notices to the association members involved in vehicles clearance. He said that the association has instructed its members to provide maximum cooperation with the investigation and furnish all requested clearance records to the authorities. Meanwhile sources informed that the crackdown was initiated following direct instructions from Prime Minister Shahbaz Sharif, who ordered comprehensive action to stop the exploitation of overseas Pakistani passports for misusing personal baggage, transfer of residence, and gift schemes in the import of old/ used vehicles. The Prime Minister's directive is now reflecting zero-tolerance approach against the systematic abuse of schemes, which although intended to facilitate overseas Pakistanis for their legitimate personal imports, being misused for years. The government had previously attempted to address the issue by introducing additional legal requirements in the Import Policy Order, 2022, implemented in 2019 for old/used vehicle imports under these schemes. These regulations mandated that all duties and taxes for vehicles imported under transfer of residence, personal baggage, or gift schemes must be paid using foreign exchange arranged by Pakistani nationals themselves or local recipients, supported by bank encashment certificates showing conversion of foreign remittance to local currency. It also restricted that remittances for duty and tax payments must originate from the account of the Pakistani national sending the vehicle from abroad, and must be received either in the sender's account or, if that account is non-existent or inoperative, in a family member's account. To ensure compliance, the government made submission of Proceed Realization Certificates mandatory, including details of remitting banks, remitter names, beneficiary information, account numbers, certificate amounts, and beneficiary banks verified by head offices. However, customs authorities have found a new pattern of fraud where unscrupulous elements involved in vehicle clearance have been submitting fake Proceed Realization Certificates in collusion with various private banks. These fraudulent certificates were being verified by the banks themselves, enabling the illegal clearance of vehicles, sources said, suggesting that the ongoing crackdown may not have lasting impact without comprehensive policy reform. They said that the government collected over Rs. 100 billion through old/used vehicle imports but didn't promulgate any policy for commercial imports, urging the government to introduce a commercial import policy to completely eliminate such illicit activities. Copyright Business Recorder, 2025
